|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2005-9-12
|
|
pubmed:abstractText |
Poor treatment outcome remains high in patients with squamous cell carcinoma (SCC) of the head and neck region. Treatment of head and neck cancer could be improved and perhaps standardized if reliable markers for tumor progression and poor prognosis could be developed. MR spectroscopy has been used previously to differentiate between malignant and adjacent normal specimen in these cancers. This study explores the capability of MR spectroscopy in providing an indication of the aggressiveness of a tumor and its response to treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0195-6108
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2108-13
|
|
pubmed:dateRevised |
2008-2-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16155166-Carcinoma, Squamous Cell,
pubmed-meshheading:16155166-Choline,
pubmed-meshheading:16155166-Creatine,
pubmed-meshheading:16155166-Female,
pubmed-meshheading:16155166-Head and Neck Neoplasms,
pubmed-meshheading:16155166-Humans,
pubmed-meshheading:16155166-Lactic Acid,
pubmed-meshheading:16155166-Lipids,
pubmed-meshheading:16155166-Magnetic Resonance Spectroscopy,
pubmed-meshheading:16155166-Male,
pubmed-meshheading:16155166-Middle Aged,
pubmed-meshheading:16155166-Predictive Value of Tests,
pubmed-meshheading:16155166-Sensitivity and Specificity,
pubmed-meshheading:16155166-Treatment Failure
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy.
|
|
pubmed:affiliation |
Institute for Biodiagnostics, National Research Council, University of Manitoba, Canada.
|
|
pubmed:publicationType |
Journal Article
|
